Do Antibacterial skin sutures reduce surgical site infections after open abdominal surgery?

Not Applicable

• Conditions: T81.4; Infection following a procedure, not elsewhere classified

• Registration Number: DRKS00010047
• Lead Sponsor: Agaplesion Diakonieklinikum Rotenburg Wümme, Klinik für Allgemein-, Viszeral- und Thoraxchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-05
• Study Completion: 2020-10-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 364

Inclusion Criteria

planned laparotomy, elucidation

Exclusion Criteria

emergency, allergy to the suture, participation to a competing study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is the occurrence of SSI defined by the CDC guidelines1 as superficial or deep incisional or either organ space infection. SSI is measured in incisional wounds after open abdominal surgery with skin suture with triclosan-coated poliglecaprone 25 (Monocryl plus; Ethicon GmbH, Norderstedt, Germany) in comparison with normal poliglecaprone 25 (Monocryl; Ethicon GmbH, Norderstedt, Germany) within 30 days after surgery

Secondary Outcome Measures

Name	Time	Method
Secondary endpoints of this study are wound dehiscence and re-operation rate due to wound dehiscence, all-cause 30-day mortality and length of hospital stay.